Results 201 to 210 of about 23,280 (232)

Epigenetic control of antigen presentation failure in osteosarcoma: from single-cell chromatin maps to therapeutic strategies. [PDF]

Front Immunol
He Y, Wu H.
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 10 No. 2 [PDF]

, 1974

core   +1 more source

Tumor‐Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities

Advanced Science, EarlyView.
ABSTRACT Despite the transformative impact of cancer immunotherapies such as immune checkpoint blockade, durable clinical responses remain limited. Increasing evidence indicates that antitumor immunity is governed not only by the tumor microenvironment, but also by systemic immune regulation mediated by peripheral immune organs. Among these, the spleen
Yuehua Liu, Xiaoqian Nie, Xiaofei Gao
wiley   +1 more source

Biological Effects of F(ab')2 Fragments Generated by Imlifidase From Anti-HLA IgG Antibodies From Transplant Patients. [PDF]

HLA
Devriese M, Carelli I, Giraldo L, Pin A, Groshaeny N, Silva SD, Bockermann R, Taupin JL.   +7 more
europepmc   +1 more source

Pyroptosis‐Inducing Engineered Microparticles for Cancer Immunotherapy

Advanced Science, EarlyView.
Engineered microparticles co‐delivering geldanamycin and dual nanobodies induce targeted pyroptosis and block PD‐L1 and CD47 pathways, reprogramming the tumor microenvironment and achieving potent antitumor immunity in lung cancer models with minimal toxicity.
Tianli Hao, Zihan Deng, Yufei Liu, Li Liu, Deqiang Deng, Muyang Yang, Yuanyuan Geng, Yao Sun, Beilei Yue, Jonathan F. Lovell, Yushuai Liu, Lisen Lu, Honglin Jin   +12 more
wiley   +1 more source

Evaluation of Antibodies Induced by Melanoma Helper Peptide Vaccine and Their Modulation by Vaccine Adjuvants. [PDF]

Vaccines (Basel)
Ashkani EG, Dickinson AM, Olson WC, Taylor JJ, Slingluff CL.   +4 more
europepmc   +1 more source

Five Years Follow-up of Imlifidase Desensitized Kidney Transplant Recipients. [PDF]

Transpl Int
Lorant T, Lonze BE, Montgomery RA, Desai NM, Legendre C, Lundgren T, von Zur-Mühlen B, Vo AA, Sjöholm K, Runström A, Tollemar J, Jordan SC.   +11 more
europepmc   +1 more source

Case Report: Zolbetuximab-induced gastritis with protein-losing gastroenteropathy and hypogammaglobulinemia: a case implicating IgA vasculitis. [PDF]

Front Oncol
Mitsui Y, Sato Y, Shinomiya R, Sumida S, Fujimoto S, Okada A, Mitsuhashi T, Kawaguchi T, Kagemoto K, Kida Y, Okamoto K, Uehara H, Takayama T.   +12 more
europepmc   +1 more source

Successful treatment of anti-neutrophil cytoplasmic antibody-associated inflammatory pseudotumour with rituximab: A case report. [PDF]

Medicine (Baltimore)
Gao L, Zhao H, Liang C, Tang H.
europepmc   +1 more source

IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapy. [PDF]

Oncoimmunology
Portillo AL, Mehboob M, Snyder G, Moinuddin A, Ritchie TM, Balint E, Moore AE, Sookhaklari M, Bramson JL, Lee DA, Naeimi Kararoudi M, Ashkar AA.   +11 more
europepmc   +1 more source